JP Morgan Chase
OPTR

JP Morgan Chase’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

JP Morgan Chase’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-29,998
Closed -$378K – 4477
2013
Q3 		$378K Sell
29,998
-294,361
-91% -$3.9M ﹤0.01% 3765
2013
Q2 		$4.69M Buy
+324,359
New +$4.72M ﹤0.01% 2183

JP Morgan Chase's OPTR Position: Q4 2013 in Review

JP Morgan Chase sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 29,998 shares — an estimated $378K sold.

JP Morgan Chase first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $4.69M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • JP Morgan Chase reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • JP Morgan Chase sold 29,998 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $378K.
  • JP Morgan Chase first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • JP Morgan Chase's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $4.69M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on JP Morgan Chase's 13F filing for Q4 2013, filed 13 Feb 2014.